Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
PP&E Gross
Samsung Biologics Co Ltd
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
PP&E Gross
₩4.8T
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
PP&E Gross
₩280.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
PP&E Gross
₩31.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
PP&E Gross
₩25.4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
18%
|
CAGR 10-Years
36%
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
PP&E Gross
₩39.1B
|
CAGR 3-Years
191%
|
CAGR 5-Years
98%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's PP&E Gross?
PP&E Gross
4.8T
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's PP&E Gross amounts to 4.8T KRW.
What is Samsung Biologics Co Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
23%
Over the last year, the PP&E Gross growth was 19%. The average annual PP&E Gross growth rates for Samsung Biologics Co Ltd have been 38% over the past three years , 23% over the past five years .